These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 12778840)

  • 21. Neuropsychological predictors of the attainment of treatment objectives in substance abuse patients.
    Teichner G; Horner MD; Harvey RT
    Int J Neurosci; 2001; 106(3-4):253-63. PubMed ID: 11264924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adoption study demonstrating two genetic pathways to drug abuse.
    Cadoret RJ; Yates WR; Troughton E; Woodworth G; Stewart MA
    Arch Gen Psychiatry; 1995 Jan; 52(1):42-52. PubMed ID: 7811161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [What support of young presenting a first psychotic episode, when schooling is being challenged?].
    Vacheron MN; Veyrat-Masson H; Wehbe E
    Encephale; 2017 Dec; 43(6):570-576. PubMed ID: 29128195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Problems in the application of the Addiction Severity Index (ASI) in rural substance abuse services.
    Wertz JS; Cleaveland BL; Stephens RS
    J Subst Abuse; 1995; 7(2):175-88. PubMed ID: 7580228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychosocial interventions for cannabis use disorder.
    Gates PJ; Sabioni P; Copeland J; Le Foll B; Gowing L
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD005336. PubMed ID: 27149547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New perspectives on the similarities and differences of alcoholism and drug abuse.
    Keeley KA; Solomon J
    Curr Alcohol; 1981; 8():99-118. PubMed ID: 6123411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cluster-randomized controlled trial evaluating the effects of delaying onset of adolescent substance abuse on cognitive development and addiction following a selective, personality-targeted intervention programme: the Co-Venture trial.
    O'Leary-Barrett M; Mâsse B; Pihl RO; Stewart SH; Séguin JR; Conrod PJ
    Addiction; 2017 Oct; 112(10):1871-1881. PubMed ID: 28544009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of primary medical care on addiction and medical severity in substance abuse treatment programs.
    Friedmann PD; Zhang Z; Hendrickson J; Stein MD; Gerstein DR
    J Gen Intern Med; 2003 Jan; 18(1):1-8. PubMed ID: 12534757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders.
    Barrowclough C; Haddock G; Tarrier N; Lewis SW; Moring J; O'Brien R; Schofield N; McGovern J
    Am J Psychiatry; 2001 Oct; 158(10):1706-13. PubMed ID: 11579006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cloninger's tridimensional theory of personality and psychopathology: applications to substance use disorders.
    Howard MO; Kivlahan D; Walker RD
    J Stud Alcohol; 1997 Jan; 58(1):48-66. PubMed ID: 8979213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral interventions for dual-diagnosis patients.
    Goldsmith RJ; Garlapati V
    Psychiatr Clin North Am; 2004 Dec; 27(4):709-25. PubMed ID: 15550289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of neuromodulation on cognitive performance in individuals exhibiting addictive behaviour: a systematic review protocol.
    Naish KR; Vedelago L; MacKillop J; Amlung M
    Syst Rev; 2018 Jun; 7(1):90. PubMed ID: 29945682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Children of substance abusers: overview of research findings.
    Johnson JL; Leff M
    Pediatrics; 1999 May; 103(5 Pt 2):1085-99. PubMed ID: 10224196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Offenders with mental health problems and problematic substance use: affective psychopathic personality traits as potential barriers to participation in substance abuse interventions.
    Durbeej N; Palmstierna T; Berman AH; Kristiansson M; Gumpert CH
    J Subst Abuse Treat; 2014; 46(5):574-83. PubMed ID: 24512943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacotherapy of dual substance abuse and dependence.
    Kenna GA; Nielsen DM; Mello P; Schiesl A; Swift RM
    CNS Drugs; 2007; 21(3):213-37. PubMed ID: 17338593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treating substance abuse: partner and family approaches.
    Klostermann K; O'Farrell TJ
    Soc Work Public Health; 2013; 28(3-4):234-47. PubMed ID: 23731417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychiatric comorbidity in forensic psychiatry.
    Palijan TZ; Muzinić L; Radeljak S
    Psychiatr Danub; 2009 Sep; 21(3):429-36. PubMed ID: 19794370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coerced treatment for substance abuse problems detected through workplace urine surveillance: is it effective?
    Lawental E; McLellan AT; Grissom GR; Brill P; O'Brien C
    J Subst Abuse; 1996; 8(1):115-28. PubMed ID: 8743772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential relationships between continuity of care practices, engagement in continuing care, and abstinence among subgroups of patients with substance use and psychiatric disorders.
    Schaefer JA; Cronkite RC; Hu KU
    J Stud Alcohol Drugs; 2011 Jul; 72(4):611-21. PubMed ID: 21683043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.